KR20170007653A - Method for Detecting Dopamine - Google Patents
Method for Detecting Dopamine Download PDFInfo
- Publication number
- KR20170007653A KR20170007653A KR1020150098506A KR20150098506A KR20170007653A KR 20170007653 A KR20170007653 A KR 20170007653A KR 1020150098506 A KR1020150098506 A KR 1020150098506A KR 20150098506 A KR20150098506 A KR 20150098506A KR 20170007653 A KR20170007653 A KR 20170007653A
- Authority
- KR
- South Korea
- Prior art keywords
- dopamine
- quantum dot
- fluorescence
- concentration
- quantum dots
- Prior art date
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
Abstract
The present invention relates to a dopamine detection method. More particularly, the present invention relates to a method of preparing a dopamine-containing solution, comprising: (i) contacting a core / shell quantum dot with a dopamine-containing solution using a crosslinking agent; (ii) detecting fluorescence extinction of the quantum dot after oxidizing dopamine bound to the quantum dot; And (iii) determining the concentration of the dopamine by comparing the fluorescence quenching and the reference fluorescence quenching.
Description
The present invention relates to a dopamine detection method. More particularly, the present invention relates to a method of preparing a dopamine-containing solution, comprising: (i) contacting a core / shell quantum dot with a dopamine-containing solution using a crosslinking agent; (ii) detecting fluorescence extinction of the quantum dot after oxidizing dopamine bound to the quantum dot; And (iii) determining the concentration of the dopamine by comparing the fluorescence quenching and the reference fluorescence quenching.
In recent years, the easy, and low cost, few studies have been carried out for the production of more various types of biosensors have the advantages of generating the exact signal (APF Turner, Chem. Soc. Rev. 42, 3184 (2013)).
Dopamine (DA) (3,4-dihydroxyphenylethylamine) is one of the most important catechol neurotransmitters. In 1958, Swedish scientist Arivd Carlsson first reported that dopamine is present in high concentrations in the striatum, about 70% of the total brain, and that dopamine is a neurotransmitter in the brain.
The important role of dopamine in hormone, kidney, myocardial and central nervous system functions is well known. Some serious diseases such as Parkinson's disease and epilepsy are associated with dopamine deficiency. Since dopamine concentration is a major marker for biological research and clinical diagnosis, there is a need to produce selective, sensitive and rapid dopamine detection materials.
However, the concentration of dopamine in vivo is very low. For example, the dopamine concentration in the extracellular fluid of the central nervous system is less than 100 nM. Moreover, the dopamine concentration varies widely from 1.0 x 10 -7 M to 1.0 x 10 -3 M depending on time and location.
The quantum dot is a fluorescent semiconductor nanoparticle having a confined exciton confined in all three directions. Compared with organic fluorescent dyes, quantum dots have promising optical properties and attractive electrochemical properties such as high quantum yield, narrow emission peak, strong signal intensity, and adjustable photoluminescence, It is collecting. Specifically, significant advances have been made in applying quantum dots to biological probes. Due to the small size of the functionalized quantum dot, significant fluorescent quenching by rapid electron energy transfer (EET) to the target molecule surface occurs.
Methods have been developed for direct measurement of dopamine, including flow-injection analysis, spectrophotometry, high performance liquid chromatography (HPLC), transistor-based sensing, and electrochemical detection. The emergence of nanotechnology has led to the development of new dopamine detection methods using nanomaterials. For example, Ganguly et al. Produced a dopamine sensor based on silver nanoparticles (M. Ganguly, C. Mondal, J. Jana, A. Pal, and T. Pal, Langmuir 30, 4120 (2014) was produced dopamine sensor of the carbon nanotube-based (RE Sabzi, K. Rezapour and N. Samad, J. Serb Chem Soc 75, 537 (2010)...), Zhao et quantum dots of dopamine-enhanced chemiluminescence detection (QD-enhanced chemiluminescence detection) (Y. Zhao, S. Zhao, J. Huang, and F. Ye, Talanta 85, 2650 (2011)). However, these prior art techniques use two-step detection based on surface modification of nanomaterials.
In the present invention, a method for detecting an in situ dopamine using a carboxyl CdSe / ZnS quantum dot is disclosed. Dopamine is conjugated to the quantum dots using a crosslinking agent such as 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride and sulfo-N-hydroxysuccinimide. Detect dopamine in situ through fluorescence quenching of the quantum dots by dopamine.
It is an object of the present invention to provide a method of preparing a dopamine-containing solution, comprising: (i) contacting a core / shell quantum dot with a dopamine-containing solution using a crosslinking agent; (ii) detecting fluorescence extinction of the quantum dot after oxidizing dopamine bound to the quantum dot; And (iii) obtaining the concentration of the dopamine by comparing the fluorescence extinction degree and the reference fluorescence extinction coefficient.
That is, the present invention provides a simple and easy method for detecting the concentration of dopamine present in a trace amount in a sample through fluorescence quenching of a quantum dot.
The above-described object of the present invention is achieved by a process for preparing a dopamine-containing solution comprising: (i) contacting a core / shell quantum dot with a dopamine-containing solution using a crosslinking agent; (ii) detecting fluorescence extinction of the quantum dot after oxidizing dopamine bound to the quantum dot; And (iii) obtaining the concentration of the dopamine in comparison with the fluorescence extinction and the reference fluorescence extinction.
As used herein, "fluorescence quenching" means any process that reduces the fluorescence intensity of a substance. A variety of molecular interactions result in the fluorescence quenching. Such molecular interactions include excited-state reactions, molecular rearrangements, energy transfer, ground-state complex formation, and collisional quenching.
In this specification, "electronic energy transfer (EET)" is a mechanism for describing energy transfer between two photosensitive molecules (chromophore). Donor chromophore, initially in an electronically excited state, can transfer energy to a dipole-dipole coupling through a non-radioactive dipole-dipole coupling. Since the efficiency of this energy transfer is inversely proportional to the sixth power of the distance between donor and acceptor, EET is very sensitive to intermolecular distance.
In the process of the present invention, the crosslinking agent may be a mixture of N- (3-Dimethylaminopropyl) -N-ethylcarbodiimide (EDC) and sulfo-N-hydroxysuccinimide (sulfo-NHS).
In this specification, the quantum dot preferably uses a quantum dot having a core / shell structure. The quantum dots are so large in surface area to volume ratio that most of the constituent atoms are exposed on the surface, leaving the atoms or molecular orbits in a completely unbonded form, which can act as a defect site for quenching the fluorescence of the quantum dots. For this reason, a shell of another semiconductor having a wider band gap is grown on the surface of the core to obtain an electromagnetic insulating effect. Moreover, the shell serves to stabilize and enhance the fluorescence emitted by the excited core, preferably passivating the core with a higher band gap than the core, so that the excitation of the quantum dots is confined to the core, Not only protects against oxidation, but also prevents Cd / Se from leaching into the surrounding solution. According to the present invention, preferably, quantum dots of a CdSe / ZnS core / shell structure can be used.
According to the present invention, the size of the core quantum dot may preferably be about 5 nm to about 12 nm. When the diameter is too small or too large, it is difficult to realize the light emission characteristics due to the decrease in stability or it may be difficult to emit light in the desired wavelength range. For example, quantum dots with a core of 3 nm CdSe emit 520 nm light while quantum dots with a core of 5.5 nm CdSe emit 630 nm light, and the emission width is affected by the size distribution.
In the method of the present invention, the core quantum dots include a group II-VI compound, such as CdSe, CdTe, ZnS, ZnSe, ZnTe, ZnO, HgS, Temple of such HgSeS, HgSeTe, HgSTe, CdZnS, CdZnSe, CdZnTe, CdHgS, CdHgSe, CdHgTe, HgZnS, HgZnSe including three won small compound, or HgZnTe, CdZnSeS, CdZnSeTe, CdZnSTe, CdHgSeS, CdHgSeTe, CdHgSTe, HgZnSeS, HgZnSeTe, HgZnSTe of Lt; / RTI > GaN, GaN, GaN, GaSb, GaPAs, GaPSb, AlNP, AlNAs, AlNSb, InN, InS, InSb, , AlPAs, AlPSb, InNP, InNAs, InNSb, InPAs, InPSb, GaAlNP, or GaAlNAs, GaAlNSb, GaAlPAs, GaAlPSb, GaInNP, GaInNAs, GaInNSb, GaInPAs, GaInPSb, InAlNP, InAlNAs, InAlNSb, InAlPAs, InAlPSb ≪ / RTI > SnSeS, SnSeTe, SnSTe, PbSeS, PbSeTe, PbSTe, SnPbS, SnPbSe, SnPbTe, or SnPbSSe, SnPbSeTe, or SnPbSeTe , SnPbSTe, and the like; Group IV compounds may be selected from single elements such as Si and Ge or these element compounds such as SiC and SiGe.
In addition, the shell portion may be made of any one of ZnO, ZnS, ZnSe, ZnTe, CdO, CdS, CdSe, CdTe, MgS, MgSe, GaAs, GaN, GaP, GaAs, GaSb, HgO, HgS, HgSe, HgTe, InAs, InSb, AlAs, AlN, AlP, or AlSb. The thickness of the shell portion may be between 8 nm and 10 nm.
In one embodiment of the present invention, the core / shell quantum dot is a CdSe / ZnS core / shell quantum dot. According to one embodiment of the present invention, a carboxyl group may be introduced on the shell surface of the quantum dot to facilitate bonding with dopamine. The solution containing the CdSe / ZnS core / shell quantum dot is contacted with a substance containing dopamine. At this time, the CdSe / ZnS core / shell quantum dots and dopamine are bonded to each other using EDC and sulfo-NHS as a crosslinking agent to bond the quantum dots to the dopamine. The pH of the binding process between the quantum dot and the dopamine may be 1-13.
After the quantum dot and dopamine are conjugated, dopamine is easily oxidized by oxygen or an electron donor. After the dopamine oxide, o-oxide of dopamine (dopamine oxide) from the quantum dot-a by electron extractor nongi energy transfer to (o -quinone group) the fluorescence intensity of the quantum dots is a quencher. At this time, the fluorescence extinction degree of the quantum dot depends on the dopamine concentration. Thus, the amount of dopamine can be measured by measuring the fluorescence quenching of such dopamine-conjugated quantum dots.
The principle of fluorescence quenching is shown in Fig. First, dopamine is conjugated to the surface of the quantum dots and the dopamine is oxidized to dopamine- o -quinone in an alkaline solution. And the fluorescence intensity of the quantum dots is extinguished by electron transfer from the quantum dots to the o -quinone group of the dopamine oxide. When the dopamine concentration is different, the fluorescence quenching is different. Based on this fluorescence quenching, dopamine can be detected.
More specifically, the fluorescence extinction degree is determined for a pH of 1-13 using a sample for which the concentration of dopamine is known. A reference fluorescence extinction graph is created using the fluorescence extinction data (see FIG. 3H). Thereafter, the pH value is adjusted (for example, pH 9) for an unknown sample of which the dopamine concentration is not known, and then the fluorescence quenching degree for the unknown sample is measured. Finally, the concentration of the unknown sample can be determined by interpolating the pH and fluorescence extinction value of the unknown sample in the reference fluorescence extinction graph (FIG. 3h).
According to the method of the present invention, dopamine can be detected in situ on a nanoscale using a quantum dot-based biosensor. The method of the present invention is very simple and has a very low detection limit, so it can be applied to direct detection of dopamine in vivo.
1 shows the structure of dopamine-coupled quantum dots and the photoluminescence quenching through electron energy transfer.
2 (a) to 2 (g) show the photoluminescence intensity spectra of dopamine-bonded quantum dots with increasing pH in an aqueous solution (a) pH = 1; b = (D) pH = 7; (e) pH = 9; (f) pH = 11; (g) pH = 13) As shown in FIG.
Figures 3 (a) -3 (g) illustrate the dopamine concentration at various external pH conditions (a) 1 nM; (b) 10 nM; (c) 100 nM; (d) 1 μM; (e) 10 μM; FIG. 3 (h) shows the photoluminescence (fluorescence) extinction of quantum dots as a function of pH at the emission peak, and FIG. 3 give.
FIG. 4 is a photoluminescence emission spectrum of the dopamine-conjugated quantum dot one day after dopamine concentration of 10 μM.
5 is a photoluminescence spectrum (pH 9) of a dopamine-bonded quantum dot after the addition of an extra quantum dot.
The present invention can be all accomplished by the following description. The following description should be understood to describe preferred embodiments of the present invention, but the present invention is not necessarily limited thereto.
Example
The CdSe / ZnS carboxyl quantum dots (CdSe / ZnS carboxyl QD) were conjugated with dopamine using the EDC / sulfo-NHS bridging method. The photoluminescence intensity (PL intensity) of the quantum dot was measured in various dopamine concentrations and various pH solutions.
First, 5 μL of a carboxyl CdSe / ZnS quantum dot (QD605-Carboxyl, Invitrogen) and 10 μM EDC (1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride) were dissolved in 100 μL of phosphate buffered saline . After 5 minutes, the mixture was dissolved in 5 mL of deionized water. 5 μM of sulfo-NHS (sulfo-N-hydroxysuccinimide) was added together while changing the dopamine concentration from 1 nM to 1 mM in a 10-fold average interval. The experiment was carried out with the pH of the solution gradually changing from 1 to 13. Fluorescence extinction was investigated using a cubic cell-using spectrofluorometer.
As shown in Fig. 1, dopamine molecules were bonded to the surface of CdSe / ZnS quantum dots. Dopamine is easily oxidized, not only by oxygen, but also by electron donors, especially in alkaline solutions. Due to electron energy transfer, the emission PL intensity of the dopamine-conjugated quantum dot (DA @ QD) is easily quenched. Furthermore, under high alkalinity, DA @ QD fluorescence was strongly quenched as shown in FIG. The photoluminescence intensity before dopamine implantation was normalized based on the intensity of the quantum dot. All experiments (7 total) were carried out with definite pH values.
Figure 2 shows that the fluorescence quenching of the quantum dots is dependent on dopamine concentration. Generally, the photoluminescence intensity of the quantum dot decreases with increasing dopamine concentration. However, as shown in Figure 2 (f), the photoluminescence intensity at 100 μM dopamine was greater than the photoluminescence intensity at 1 mM dopamine, which would be due to the oxidation of dopamine. At
4 shows the photoluminescence emission spectrum of DA @ QD after one night. Under acidic conditions, dopamine was not oxidized. At
Experiments were also conducted to demonstrate this assumption. Extra quantum dots were added to the DA @ QD mixture and the photoluminescence spectra were measured after 1 minute and 1 day. The photoluminescence spectrum of this complex is shown in Figure 5 (pH 9). The emission spectrum of DA @ QD, shown in red, showed one peak at 480 nm, which signifies oxidation of dopamine, and another peak at 605 nm by the quantum dot. After the addition of extra quantum dots, the peak at 605 nm immediately improved and the peak at 480 nm remained unchanged, indicating that dopamine was not oxidized. However, after 24 hours, the peak at 605 nm was completely extinguished and the peak at 480 nm improved, which may be due to increased dopamine oxidation by the extra quantum dot. These results show that fluorescence quenching allows DA @ QD to be used as a sensing medium for the detection of pH, oxygen and other oxidizing agents.
It will be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention as defined by the appended claims.
Claims (4)
(ii) detecting fluorescence extinction of the quantum dot after oxidizing dopamine bound to the quantum dot; And
(iii) determining the concentration of the dopamine in comparison with the fluorescence quenching and the reference fluorescence quenching.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150098506A KR101764005B1 (en) | 2015-07-10 | 2015-07-10 | Method for Detecting Dopamine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150098506A KR101764005B1 (en) | 2015-07-10 | 2015-07-10 | Method for Detecting Dopamine |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170007653A true KR20170007653A (en) | 2017-01-19 |
KR101764005B1 KR101764005B1 (en) | 2017-08-02 |
Family
ID=57990820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150098506A KR101764005B1 (en) | 2015-07-10 | 2015-07-10 | Method for Detecting Dopamine |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101764005B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106970061A (en) * | 2017-05-10 | 2017-07-21 | 青岛大学 | The preparation method of carbon point/copper nano-cluster compound ratio fluorescent dopamine probe |
KR20180098088A (en) * | 2017-02-24 | 2018-09-03 | 한양대학교 에리카산학협력단 | Nanoprobe for detecting dopamine, sensor for detecting dopamine containing the same and sensing method for dopamine |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102063660B1 (en) | 2018-02-28 | 2020-01-08 | 경북대학교 산학협력단 | Boronic acid-carbon dot complex having selective detection properties of dopamine, a method for producing the same, and a dopamine biosensor using the same |
CN109490269B (en) * | 2018-12-07 | 2020-07-24 | 吉林大学 | Preparation method of dual-emission colorimetric fluorescent nano-microsphere and application of dual-emission colorimetric fluorescent nano-microsphere in bacterial detection |
KR102064326B1 (en) | 2019-07-17 | 2020-01-09 | 경북대학교 산학협력단 | Gold nanoparticle-phosphor hybrid material and its preparing methods |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103232845B (en) | 2013-05-08 | 2014-08-27 | 安徽工业大学 | Preparation and application for silicon quantum dots |
-
2015
- 2015-07-10 KR KR1020150098506A patent/KR101764005B1/en active IP Right Grant
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180098088A (en) * | 2017-02-24 | 2018-09-03 | 한양대학교 에리카산학협력단 | Nanoprobe for detecting dopamine, sensor for detecting dopamine containing the same and sensing method for dopamine |
CN106970061A (en) * | 2017-05-10 | 2017-07-21 | 青岛大学 | The preparation method of carbon point/copper nano-cluster compound ratio fluorescent dopamine probe |
Also Published As
Publication number | Publication date |
---|---|
KR101764005B1 (en) | 2017-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101764005B1 (en) | Method for Detecting Dopamine | |
Schiffman et al. | Quantum dots as fluorescent probes: Synthesis, surface chemistry, energy transfer mechanisms, and applications | |
Li et al. | Quantum dots for fluorescent biosensing and bio-imaging applications | |
Yuan et al. | Highly selective and sensitive detection of mercuric ion based on a visual fluorescence method | |
KR102220405B1 (en) | Optical elements and electronic devices including the same | |
Costa-Fernández et al. | The use of luminescent quantum dots for optical sensing | |
Díaz‑González et al. | Quantum dot bioconjugates for diagnostic applications | |
Petryayeva et al. | Quantum dots in bioanalysis: a review of applications across various platforms for fluorescence spectroscopy and imaging | |
Das et al. | Cancer biomarker determination by resonance energy transfer using functional fluorescent nanoprobes | |
Shi et al. | Autoluminescence-free dual tumor marker biosensing by persistent luminescence nanostructures | |
KR101674412B1 (en) | Quantum dot bead sensor and manufacturing method threof | |
Kavosi et al. | Amplified fluorescence resonance energy transfer sensing of prostate specific antigen based on aggregation of CdTe QDs/antibody and aptamer decorated of AuNPs-PAMAM dendrimer | |
KR101486697B1 (en) | Spectroscopy-active metal nanoparticles | |
KR20180005164A (en) | Continuously emissive core/shell nanoplatelets | |
Tu et al. | Time-gated imaging on live cancer cells using silicon quantum dot nanoparticles with long-lived fluorescence | |
JP7369414B2 (en) | Analyte detection | |
Shi et al. | Stable upconversion nanohybrid particles for specific prostate cancer cell immunodetection | |
KR20170007641A (en) | Method for Preparing Core/Shell Quantum Dot | |
US10824011B2 (en) | Photoluminescent polarizers having metal film with surface plasmon coupling and electronic devices including the same | |
EP3537138B1 (en) | Quantum dot biosensor | |
US20210072239A1 (en) | Biosensor comprising linker material and quantum dot beads, and target antigen detection method using same | |
Sui et al. | Plasmon-controlled narrower and blue-shifted fluorescence emission in (Au@ SiO 2) SiC nanohybrids | |
KR20190136319A (en) | Method for detecting targent antigen and biological diagnosis device by using quantom-dot and quantom-dot bead comprising multifunctional ligand | |
KR101938374B1 (en) | Fret-based target molecule detection system, kit thereof and method for detecting target molecule using the same | |
KR101796351B1 (en) | Method for Preparing Polymer-Encapsulated Quantum Dot Magnetice Nanoparticle via Electrohydrodynamic Co-Jetting |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |